window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers & Shakers

  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    Allucent has appointed new therapeutic strategy leaders across key disease [...]

    April 9, 2026
  • Healthcare leadership,Mergers & Acquisitions,Movers & Shakers,Pharmaceuticals and therapeutics

    Genmab appoints Margarida Duarte as general manager for Europe and emerging markets

    Genmab has appointed Margarida Duarte as general manager, Europe and [...]

    April 8, 2026
  • Healthcare leadership,Market Access & Commercialization,Movers & Shakers,Pharmaceuticals and therapeutics,Startups and innovations

    Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America

    Opella has appointed Gonzalo Balcazar as president of Europe and [...]

    April 8, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline

    Orano has appointed Frederic Desdouits as chief executive officer of [...]

    April 8, 2026
  • Biotech,Clinical Development,Clinical Trials,Healthcare leadership,Immunology,Movers & Shakers

    Aravax adds allergy specialists to board as peanut therapy advances

    Aravax has appointed two senior industry figures to its board [...]

    April 8, 2026
  • Biotech,Drug discovery,Healthcare leadership,Movers & Shakers,Research & Development,Startups and innovations,Technology and platforms

    Proxygen appoints Chiara Conti as chief scientific officer to support move into clinical-stage development

    Proxygen has appointed Chiara Conti as chief scientific officer, as [...]

    April 2, 2026
  • Healthcare leadership,Movers & Shakers

    Abselion hires Dale Gordon as chair to support growth push

    Abselion has appointed Dale Gordon as chair as the company [...]

    March 23, 2026
  • Biologics & Biosimilars,Biotech,Drug discovery,European biotech,Healthcare leadership,Movers & Shakers,Opthalmology,Research & Development

    Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic

    Link Biologics has appointed Niall Martin to its board as [...]

    February 25, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics

    Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership

    Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

    February 20, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,European biotech,Facilities and infrastructure,Healthcare leadership,Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics

    Axplora expands lyophilisation capacity at Le Mans

    Axplora is investing several million euros to expand lyophilisation capacity [...]

    February 19, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top